TG Therapeutics (TGTX) Misses Q1 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. PINS
4. COIN
5. RDDT
6. FSLR
7. SYK
8. SBUX
9. MA
10. FND

Go back to TG Therapeutics (TGTX) Misses Q1 EPS by 6c

TG Therapeutics, Inc. Announces First Quarter 2015 Financial Results and Business Update

May 4, 2015 5:01 PM EDT

NEW YORK, May 4, 2015 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq: TGTX) today announced its financial results for the first quarter ended March 31, 2015 and recent company developments.

Michael S. Weiss, the Company's Executive Chairman and Interim Chief Executive Officer, stated, "During the first quarter, we focused on site initiation and enrollment into our GENUINE Phase 3 clinical trial, as well as the continued enrollment into our Phase 1/2 trial of our proprietary combination of TG-1101 and TGR-1202, also referred to as 1303, and we look forward to presenting updated data from these studies next month.... More